
Bill Wierda, MD, PhD
29 posts

Bill Wierda, MD, PhD
@wwierda
Professor in the Department of #Leukemia at @MDAndersonNews specializing clinical research of #CLL. Tweets are my own. #endcancer







Poignantly highlighted in today's heartwarming celebration is the incredible compassion and empathy @MDAndersonNews frontline workers demonstrate each day in the fight against #COVID19. Proud of these extraordinary moments and our remarkable #healthcareheroes.


We are so enjoying @wwierda’s visit to @MayoCancerCare and discussing hot topics in #CLL - IGHV mutation status, combinations for fixed tx & optimal duration, uMRD, and plateaus that raise the question of cure in a subset of pts. Lots of great work going on at @MDAndersonNews!

@davidcnorrismd @iwCLL @anthonymatomd @tobyeyre82 @DrMDavids @sparikhmd @wwierda The trial did not report on the dose reductions and relation to outcomes. This data shows that some pts can remain progression free for sometime after stopping ibrutinib. I won’t recommend this strategy outside of a trial.

Lively debate on the value of #MRD assessment in #CLL w/ @wwierda of @MDAndersonNews and Lydia Scarfo of @MyUniSR. Full video coming soon! #iwCLL2019 @iwCLL @VJHemOnc #CLLsm #Leusm

CAR T-cell therapy is changing the way we treat B-cell #lymphoma and #ALL. Watch to learn how from our @wwierda. #CART #endcancer












